Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7508 | 1360 | 35.8 | 75% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
7508 | 1 | TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL | 1360 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | TUMOR INFILTRATING LYMPHOCYTES | authKW | 523973 | 10% | 18% | 131 |
2 | ADOPTIVE IMMUNOTHERAPY | authKW | 202169 | 6% | 12% | 76 |
3 | TIL | authKW | 94260 | 2% | 20% | 21 |
4 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 91480 | 10% | 3% | 133 |
5 | AUTOLYMPHOCYTE THERAPY | authKW | 70155 | 0% | 63% | 5 |
6 | UNITA OPERAT ASSISTENZIALE GINECOL ONCOL | address | 67352 | 0% | 100% | 3 |
7 | SURG FF50 | address | 51313 | 0% | 57% | 4 |
8 | JOURNAL OF IMMUNOTHERAPY | journal | 46405 | 4% | 4% | 59 |
9 | AUTOLOGOUS TUMOR SPECIFIC CYTOTOXICITY | authKW | 44902 | 0% | 100% | 2 |
10 | CD28 MAB | authKW | 44902 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 14282 | 53% | 0% | 718 |
2 | Immunology | 9043 | 39% | 0% | 536 |
3 | Medicine, Research & Experimental | 1290 | 12% | 0% | 169 |
4 | Pathology | 257 | 5% | 0% | 62 |
5 | Surgery | 167 | 8% | 0% | 111 |
6 | Cell Biology | 67 | 6% | 0% | 78 |
7 | Dermatology | 31 | 2% | 0% | 23 |
8 | Transplantation | 31 | 1% | 0% | 19 |
9 | Hematology | 24 | 2% | 0% | 29 |
10 | Otorhinolaryngology | 21 | 1% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNITA OPERAT ASSISTENZIALE GINECOL ONCOL | 67352 | 0% | 100% | 3 |
2 | SURG FF50 | 51313 | 0% | 57% | 4 |
3 | PATERSON IMMUNOL | 44902 | 0% | 100% | 2 |
4 | MOL TUMOR IMMUNOL | 44005 | 1% | 20% | 10 |
5 | SURG FF5 | 29933 | 0% | 67% | 2 |
6 | UNITA IMMUNOTER IA CELLULARE | 29933 | 0% | 67% | 2 |
7 | RIKEN CELL BANK | 28856 | 0% | 21% | 6 |
8 | 1 CHILDRENS PL ROOM 5725 | 22451 | 0% | 100% | 1 |
9 | ADDENBROOKES HOSP PATHOL IMMUNOL | 22451 | 0% | 100% | 1 |
10 | CATTEDRA IMMUNOL SEZ NOVARA | 22451 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 91480 | 10% | 3% | 133 |
2 | JOURNAL OF IMMUNOTHERAPY | 46405 | 4% | 4% | 59 |
3 | BIOTHERAPY | 10973 | 1% | 4% | 12 |
4 | INTERNATIONAL JOURNAL OF CANCER | 7591 | 6% | 0% | 83 |
5 | JOURNAL OF IMMUNOLOGY | 4966 | 8% | 0% | 110 |
6 | JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS | 4590 | 1% | 2% | 10 |
7 | CANCER RESEARCH | 4060 | 6% | 0% | 85 |
8 | CANCER BIOTHERAPY | 3774 | 0% | 4% | 4 |
9 | CELLULAR IMMUNOLOGY | 2900 | 2% | 0% | 32 |
10 | NATURAL IMMUNITY AND CELL GROWTH REGULATION | 2295 | 0% | 3% | 4 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | TUMOR INFILTRATING LYMPHOCYTES | 523973 | 10% | 18% | 131 | Search TUMOR+INFILTRATING+LYMPHOCYTES | Search TUMOR+INFILTRATING+LYMPHOCYTES |
2 | ADOPTIVE IMMUNOTHERAPY | 202169 | 6% | 12% | 76 | Search ADOPTIVE+IMMUNOTHERAPY | Search ADOPTIVE+IMMUNOTHERAPY |
3 | TIL | 94260 | 2% | 20% | 21 | Search TIL | Search TIL |
4 | AUTOLYMPHOCYTE THERAPY | 70155 | 0% | 63% | 5 | Search AUTOLYMPHOCYTE+THERAPY | Search AUTOLYMPHOCYTE+THERAPY |
5 | AUTOLOGOUS TUMOR SPECIFIC CYTOTOXICITY | 44902 | 0% | 100% | 2 | Search AUTOLOGOUS+TUMOR+SPECIFIC+CYTOTOXICITY | Search AUTOLOGOUS+TUMOR+SPECIFIC+CYTOTOXICITY |
6 | CD28 MAB | 44902 | 0% | 100% | 2 | Search CD28+MAB | Search CD28+MAB |
7 | CD3 MAB | 44902 | 0% | 100% | 2 | Search CD3+MAB | Search CD3+MAB |
8 | CLONOTYPIC T CELLS | 44902 | 0% | 100% | 2 | Search CLONOTYPIC+T+CELLS | Search CLONOTYPIC+T+CELLS |
9 | HUMAN AUTOLOGOUS TUMOR | 44902 | 0% | 100% | 2 | Search HUMAN+AUTOLOGOUS+TUMOR | Search HUMAN+AUTOLOGOUS+TUMOR |
10 | T CELL RECEPTOR VARIABLE GENE REPERTOIRE | 44902 | 0% | 100% | 2 | Search T+CELL+RECEPTOR+VARIABLE+GENE+REPERTOIRE | Search T+CELL+RECEPTOR+VARIABLE+GENE+REPERTOIRE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WHITESIDE, TL , JOST, LM , HERBERMAN, RB , (1992) TUMOR-INFILTRATING LYMPHOCYTES - POTENTIAL AND LIMITATIONS TO THEIR USE FOR CANCER-THERAPY.CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY. VOL. 12. ISSUE 1. P. 25-47 | 75 | 49% | 31 |
2 | YOONG, KF , ADAMS, DH , (1996) TUMOUR INFILTRATING LYMPHOCYTES: INSIGHTS INTO TUMOUR IMMUNOLOGY AND POTENTIAL THERAPEUTIC IMPLICATIONS.JOURNAL OF CLINICAL PATHOLOGY-CLINICAL MOLECULAR PATHOLOGY EDITION. VOL. 49. ISSUE 5. P. M256-M267 | 66 | 49% | 4 |
3 | SCHONDORF, T , ENGEL, H , LINDEMANN, C , KOLHAGEN, H , VONRUCKER, AA , MALLMANN, P , (1997) CELLULAR CHARACTERISTICS OF PERIPHERAL BLOOD LYMPHOCYTES AND TUMOUR-INFILTRATING LYMPHOCYTES IN PATIENTS WITH GYNAECOLOGICAL TUMOURS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 44. ISSUE 2. P. 88-96 | 41 | 73% | 25 |
4 | WHITESIDE, TL , (1992) TUMOR-INFILTRATING LYMPHOCYTES AS ANTITUMOR EFFECTOR-CELLS.BIOTHERAPY. VOL. 5. ISSUE 1. P. 47-61 | 50 | 69% | 16 |
5 | WHITESIDE, TL , PARMIANI, G , (1994) TUMOR-INFILTRATING LYMPHOCYTES - THEIR PHENOTYPE, FUNCTIONS AND CLINICAL USE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 39. ISSUE 1. P. 15-21 | 41 | 68% | 76 |
6 | ELSASSERBEILE, U , WETTERAUER, U , SCHULTZESEEMANN, W , GALLATI, H , MONTING, JS , VONKLEIST, S , (1996) ANALYSIS OF THE IMMUNE REACTIVITY OF INFILTRATING AND PERIPHERAL LYMPHOCYTES FROM PATIENTS WITH RENAL CELL CARCINOMA BY MEASURING CYTOKINE SECRETION.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 42. ISSUE 2. P. 93-98 | 31 | 89% | 6 |
7 | SUSSMAN, JJ , PARIHAR, R , WINSTEAD, K , FINKELMAN, FD , (2004) PROLONGED CULTURE OF VACCINE-PRIMED LYMPHOCYTES RESULTS IN DECREASED ANTITUMOR KILLING AND CHANGE IN CYTOKINE SECRETION.CANCER RESEARCH. VOL. 64. ISSUE 24. P. 9124-9130 | 39 | 46% | 19 |
8 | CHIN, Y , JANSSENS, J , BLEUS, J , ZHANG, JW , RAUS, J , (1994) CELLULAR AND MOLECULAR ANALYSIS OF TUMOR-INFILTRATING T-LYMPHOCYTES FROM HUMAN BREAST-CANCER AT CLONAL LEVEL.ONCOLOGY REPORTS. VOL. 1. ISSUE 3. P. 577-583 | 29 | 88% | 0 |
9 | PARMIANI, G , ANICHINI, A , FOSSATI, G , (1990) CELLULAR IMMUNE-RESPONSE AGAINST AUTOLOGOUS HUMAN-MALIGNANT MELANOMA - ARE INVITRO STUDIES PROVIDING A FRAMEWORK FOR A MORE EFFECTIVE IMMUNOTHERAPY.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 82. ISSUE 5. P. 361-370 | 50 | 51% | 68 |
10 | TOPALIAN, SL , SOLOMON, D , ROSENBERG, SA , (1989) TUMOR-SPECIFIC CYTOLYSIS BY LYMPHOCYTES INFILTRATING HUMAN MELANOMAS.JOURNAL OF IMMUNOLOGY. VOL. 142. ISSUE 10. P. 3714-3725 | 25 | 74% | 407 |
Classes with closest relation at Level 1 |